SlideShare a Scribd company logo
Regurgitant murmurs
KIBROM.MULUGETA
updated OCT 2016
SPHMMC
Lecture-1
outline
Etiology
Pathophysiology
Epidemiology
Presentation
Work up
Management
AR & MR
Etiology
acute
pathophysiology
The total stroke volume ejected by the LV
is increased in patients with AR.
 the increase in LV end-diastolic volume
(i.e., increased preload) provides
hemodynamic compensation.
In compensated AR , LV systolic function
is maintained through the combination of
chamber dilation and hypertrophy
(eccentric hypertrophy).
CON…
As the LV decompensates, LVcompliance
declines, and LV end-diastolic pressure
and volume rise.
Ultimately, these adaptive measures fail.
As LV function deteriorates, the end-
diastolic volume rises further and the
forward stroke volume and EF decline.
Con…
 In patients with acute severe AR, the LV is
unprepared for the regurgitant volume
load.
 LV compliance is normal or reduced, and
LV diastolic pressures rise rapidly,
occasionally to levels >40 mmHg.
 The LV pressure may exceed the LA
pressure toward the end of diastole, and
this reversed pressure gradient closes the
mitral valve prematurely.
Con…
 Myocardial ischemia may occur in
patients with AR because myocardial
oxygen requirements are elevated by
 LV dilation
 hypertrophy
 elevated LV systolic tension
Con…
EPIDEMIOLOGY
 The prevalence of AR varied with age and
disease severity.
 For mild AR, the prevalence was
 3.7% in men at ages 50 to 59
 12.1 % …. …. 60 to 69
 12.2 % …….. ….70 to 83
 moderate to severe AR, the prevalence
was 0.5, 0.6, and 2.2 % in men at ages 50
to 59, 60 to 69, and 70 to 83, respectively
Con…
three-fourths of patients with pure or
predominant AR are men.
women predominate among patients
with primary valvular AR who have
associated rheumatic mitral valve
disease.
Presentation
 History
 Hx cardiac illness
 Duration (acute or chronic)
 Palpitations
 exertional dyspnea
 Anginal pain
 do not respond satisfactorily to sublingual
nitroglycerin
 ankle edema
Con…
Physical Findings
Arterial Pulse
water-hammer
Corrigan's pulse
Quincke's pulse
pistol-shot(Traube's sign)
to-and-fro murmur (Duroziez's sign)
The arterial pulse pressure (widended)
Con…
 Bobbing motion of the head with each
systole(De Musset’s sign)
 A rapidly rising "water-hammer" pulse,
which collapses suddenly as arterial
pressure falls rapidly during late systole
and diastole
 Prominent carotid artery
pulsations(Corrigan's pulse)
 Quincke's pulse (capillary pulsations)
 Traube's sign, A booming "pistol-shot"
sound can be heard over the femoral
arteries
 Duroziez's sign, A to-and-fro murmur is
audible if the femoral artery is lightly
compressed with a stethoscope.
 Wide pulse pressure, elevation of the
systolic pressure and a depression of the
diastolic pressure.
Con…
 Precordial exam
 the LV impulse is heaving and displaced laterally and
inferiorly.
 A diastolic thrill is often palpable along the left sternal
border
 A prominent systolic thrill may be palpable in the
suprasternal notch
 A2 is usually absent, S3 and systolic ejection sound
are frequently audible, S4.
 A high-pitched, blowing, decrescendo diastolic
murmur, heard best in the 3rd intercostal space along
the LSB.
Con…
 A mid-systolic ejection murmur is
frequently audible and best at the base
of the heart
 Austin Flint murmur, a soft, low-pitched,
rumbling mid-diastolic murmur.
 The auscultatory features of AR are
intensified by strenuous handgrip,
which augments systemic resistance
Progress…
 Asymptomatic patients with left ventricular
dysfunction, however, develop symptoms
(angina, heart failure) at a rate of greater
than 25 % per year.
 symptomatic patients with severe aortic
regurgitation have an expected mortality
that exceeds 10 %per year.
Stages /AHA valvular heart
disease 2014
Work up
ECG:
 chronic severe AR,Left LV hypertrophy.
◦ ST-segment depression and T-wave inversion
in leads I, aVL, V5, and V6 ("LV strain").
◦ Left axis deviation and/or QRS prolongation
CXR:
 Cardiomegaly, aortic calcification, aortic root
dilatation
Echocardiography
 is useful in determining the cause of AR
 thickening and failure of coaptation of the
leaflets may be noted
 Colour flow Doppler ECHO is very
sensitive in the detection of AR,
2014 AHA/ECHO follow up
Medical treatment
- Diuretics, digoxin, salt restriction
- Vasodilators
- Endocarditis prophylaxis
◦ Without surgery, death usually
occurs within 4 years of developing
angina and within 2 years after
onset of heart failure.
surgical
 AVR(aortic valve replacement )
is indicated for the Tx of severe AR in
symptomatic pts irrespective of LV
function
It should be carried out in asymptomatic
pts with severe AR and progressive LV
dysfunction defined by
LVEF <50%,
an LV end-systolic dimension >55mm ,
or
 without indications for operation
should be followed by clinical and
ECHO examination every 3–12
months
2014 AHA/ACC Valvular Heart
Disease Guideline
Etiology
Con…
 Valve leaflets
- myxomatous degeneration
- rheumatic heart disease
- infective endocarditis
 Chordae tendinae
- congenital, infective endocarditis,
trauma, rheumatic fever, myxomatous
 Papillary muscles
- myocardial ischaemia, congenital
abnormalities, infiltrative disease
 Mitral annulus
- dilatation eg. ischaemic or dilated
cardiomyopathy
- calcification due to degeneration,
hypertension, diabetes, CKD
Pathophysiology
 The resistance to LV emptying (LV afterload) is
reduced in pts with MR. As a consequence, the
LV is decompressed into the LA during ejection.
 The initial compensation to MR is more complete
LV emptying leading to a reduced end-systolic
LV volume.
 As regurgitation becomes chronic, the LV end-
diastolic volume increases and the end-systolic
volume returns to normal.
 The resultant increase in LV end-diastolic volume
and mitral annular diameter may create a vicious
circle in which “MR begets more MR.
Ctd.
 In patients with chronic MR , LV mass is also
increased (typical volume overload
(eccentric) hypertrophy)
 The reduced afterload in MR permits
maintenance of ejection fraction in the normal
to supranormal range ,thus even a modest
reduction in the EF (<60%) reflects significant
dysfunction.
 As the disease progress and LV contractile
function deteriorates LV volume increases
accompanied by a reduced forward CO.
Clinical features
 Symptoms usually occur with LV decompensation:
Fatigue, exertional dyspnea, and orthopnea are the
most prominent complaints in pts with chronic
severe MR
 Palpitations with AF
 Sx and SSx of right-sided HF in pt who have
associated pulmonary vascular disease and
marked pulmonary HTN
 Acute pulmonary edema is common in pts with
acute severe MR b/c of markedly increase LA and
pulmonary venous pressures.
Chronic versus Acute MR
Finding Chronic MR Acute MR
Symptoms subtle onset obvious
Appearance normal/mildly
severely ill
dyspnoeic
Tachycardia not striking always present
Apex beat displaced not displaced
Systolic thrill common absent
Murmur harsh pansystolic soft or absent
early systolic
component
ECG-LVH usually present
absent
CXR severe cardiomegaly normal heart size
Physical findings
- Pulse: sharp upstroke
- BP is usually normal
- Apex:
displaced, hyperdynamic
◦ A systolic thrill is often palpable at the
cardiac apex
◦ In acute severe MR, BP may be reduced
with a narrow pulse pressure, the apical
impulse is not displaced, and signs of
pulmonary congestion are prominent.
◦ S1 is absent or soft
◦ S3
CON…
◦ S 4 in acute severe MR
◦ holosystolic murmur most prominent
at the apex and radiates to the axilla,
intensified by isometric exercise
(handgrip)
◦ In pts with ruptured chordae
tendineae, the systolic murmur may
have a cooing or "sea gull" quality
Ctd.
 ECG
◦ evidence of LA enlargement
◦ AF
◦ signs of LV hypertrophy
 Chest X-Ray
◦ Pulmonary venous congestion,
interstitial edema, and Kerley B lines
◦ Calcification of the mitral annulus
may be visualized
Ctd.
Natural history
 The natural history of chronic MR depends on the
volume of regurgitation, the state of the
myocardium and the underlying cause.
 Preoperative LV end-systolic volume or diameter
is a useful predictor of function and postoperative
survival in chronic MR.
 The preoperative LV end-systolic diameter should
be < 45mm to ensure normal postoperative LV
function
CON...
Severe MR is defined by
a regurgitant volume 60 mL/beat,
regurgitant fraction (RF) 50%,
effective regurgitant orifice area 0.40
cm2
MR and Colour flow imaging of MR
Management strategy for pts with chronic severe
MR
Medical treatment
 Symptomatic patients may benefit from the
following drug therapy while awaiting surgery:
 ACE inhibitors
 Diuretics
 Digoxin / Beta-blockers in presence of atrial
fibrillation. Plus Warfarin with a target INR of 2–3.
 Endocarditis prophylaxis
 Pts with acute severe MR require urgent
stabilization and preparation for surgery.
[Diuretics, intravenous vasodilators (sodium
nitroprusside), and even IABC].
Surgical treatment
 Surgery is indicated
◦ If symptoms developed or LV end systolic diameter
≥45mm
◦ recent-onset AF and pulmonary hypertension, (a PA
pressure 50 mmHg at rest or 60 mmHg with exercise).
◦ For asymptomatic pts when LV dysfunction is progressive,
with LVEF declining below 60% and/or ESD on ECHO
rising above 40 mm.
 Mitral valve repair or replacement.
◦ Mitral repair and valvuloplasty maintain LV function to a
relatively greater degree and avoids the need for chronic
anticoagulation.
 In pts with significantly impaired LV function (EF
<30%), the risk of surgery rises, the recovery of LV
performance is incomplete, and the long-term
survival is reduced.
Ctd.
 Natural history
 Benign prognosis in most patients
 Complications may occur in patients
with a systolic murmur, thickened
leaflets, an increased LV or LA size,
especially in men > 45 years old
• Complications include progressive
MR, infective endocarditis, cerebral
emboli, arrhythmias and rarely sudden
death.
summary
 In patients with chronic MR , LV mass
is also increased (typical volume
overload (eccentric) hypertrophy
- Apex: displaced, hyperdynamic
◦ A systolic thrill is often palpable at the
cardiac apex.
◦ a regurgitant volume < 60
mL/beat….severMR
2.5. Regurgitant Murmurs.pptx

More Related Content

Similar to 2.5. Regurgitant Murmurs.pptx

Use of echocardiography in icu
Use of echocardiography in icuUse of echocardiography in icu
Use of echocardiography in icu
Nisheeth Patel
 
aorticregurgitation-131030042922-phpapp02 (1).pptx
aorticregurgitation-131030042922-phpapp02 (1).pptxaorticregurgitation-131030042922-phpapp02 (1).pptx
aorticregurgitation-131030042922-phpapp02 (1).pptx
gfcbfd
 
pulses
pulsespulses
Pediatric cardiac-anomalies-part-3
Pediatric cardiac-anomalies-part-3Pediatric cardiac-anomalies-part-3
Pediatric cardiac-anomalies-part-3
Hue University of Medicine and Pharmacy
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
DIPAK PATADE
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Ankur Khandelwal
 
Aortic Regurgitation
Aortic RegurgitationAortic Regurgitation
Aortic Regurgitation
Prof. Dr. Aswinikumar Surendran
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
hodmedicine
 
Mitral Regurgitation
Mitral RegurgitationMitral Regurgitation
Mitral Regurgitation
Sujay Iyer
 
AORTIC VALVE DS.pptx
AORTIC VALVE DS.pptxAORTIC VALVE DS.pptx
AORTIC VALVE DS.pptx
PreetiChouhan6
 
Anaesthetic management of valvular heart disease for non cardiac surgery
Anaesthetic management of valvular heart disease for non cardiac surgeryAnaesthetic management of valvular heart disease for non cardiac surgery
Anaesthetic management of valvular heart disease for non cardiac surgery
Naveen Cheran
 
Valvular heart disease.ppt
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.ppt
RAHULSUTHAR46
 
Hemodynamics Basic Concepts
Hemodynamics Basic ConceptsHemodynamics Basic Concepts
Hemodynamics Basic Concepts
vclavir
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
Silah Aysha
 
Aortic Stenosis
Aortic StenosisAortic Stenosis
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
Davis Kurian
 
CHRONIC RHEUMATIC FEVER.pptx
CHRONIC RHEUMATIC FEVER.pptxCHRONIC RHEUMATIC FEVER.pptx
CHRONIC RHEUMATIC FEVER.pptx
miroofafrika
 
Cardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur RahmanCardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur Rahman
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Mitral regurgitation
Mitral regurgitationMitral regurgitation
Mitral regurgitation
Diaa Srahin
 
aortic valve disease.pptx
aortic valve disease.pptxaortic valve disease.pptx
aortic valve disease.pptx
mohammedirfan251692
 

Similar to 2.5. Regurgitant Murmurs.pptx (20)

Use of echocardiography in icu
Use of echocardiography in icuUse of echocardiography in icu
Use of echocardiography in icu
 
aorticregurgitation-131030042922-phpapp02 (1).pptx
aorticregurgitation-131030042922-phpapp02 (1).pptxaorticregurgitation-131030042922-phpapp02 (1).pptx
aorticregurgitation-131030042922-phpapp02 (1).pptx
 
pulses
pulsespulses
pulses
 
Pediatric cardiac-anomalies-part-3
Pediatric cardiac-anomalies-part-3Pediatric cardiac-anomalies-part-3
Pediatric cardiac-anomalies-part-3
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
 
Aortic Regurgitation
Aortic RegurgitationAortic Regurgitation
Aortic Regurgitation
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
 
Mitral Regurgitation
Mitral RegurgitationMitral Regurgitation
Mitral Regurgitation
 
AORTIC VALVE DS.pptx
AORTIC VALVE DS.pptxAORTIC VALVE DS.pptx
AORTIC VALVE DS.pptx
 
Anaesthetic management of valvular heart disease for non cardiac surgery
Anaesthetic management of valvular heart disease for non cardiac surgeryAnaesthetic management of valvular heart disease for non cardiac surgery
Anaesthetic management of valvular heart disease for non cardiac surgery
 
Valvular heart disease.ppt
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.ppt
 
Hemodynamics Basic Concepts
Hemodynamics Basic ConceptsHemodynamics Basic Concepts
Hemodynamics Basic Concepts
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Aortic Stenosis
Aortic StenosisAortic Stenosis
Aortic Stenosis
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
CHRONIC RHEUMATIC FEVER.pptx
CHRONIC RHEUMATIC FEVER.pptxCHRONIC RHEUMATIC FEVER.pptx
CHRONIC RHEUMATIC FEVER.pptx
 
Cardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur RahmanCardiac tamponade Toufiqur Rahman
Cardiac tamponade Toufiqur Rahman
 
Mitral regurgitation
Mitral regurgitationMitral regurgitation
Mitral regurgitation
 
aortic valve disease.pptx
aortic valve disease.pptxaortic valve disease.pptx
aortic valve disease.pptx
 

More from AmareDejene

upper gastrointestinal lecture slide ppt
upper gastrointestinal lecture slide pptupper gastrointestinal lecture slide ppt
upper gastrointestinal lecture slide ppt
AmareDejene
 
benigh perianal conditionsssssssss CI.pptx
benigh perianal conditionsssssssss CI.pptxbenigh perianal conditionsssssssss CI.pptx
benigh perianal conditionsssssssss CI.pptx
AmareDejene
 
solid.pptx
solid.pptxsolid.pptx
solid.pptx
AmareDejene
 
2.5. Stenotic v-2014.pptx
2.5. Stenotic v-2014.pptx2.5. Stenotic v-2014.pptx
2.5. Stenotic v-2014.pptx
AmareDejene
 
2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt
AmareDejene
 
2.8. Pericardial disease.pptx
2.8. Pericardial disease.pptx2.8. Pericardial disease.pptx
2.8. Pericardial disease.pptx
AmareDejene
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
AmareDejene
 
2.6. HTN.pptx
2.6. HTN.pptx2.6. HTN.pptx
2.6. HTN.pptx
AmareDejene
 
2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
AmareDejene
 
2.2. Acute Rheumatic Fever.ppt
2.2. Acute Rheumatic Fever.ppt2.2. Acute Rheumatic Fever.ppt
2.2. Acute Rheumatic Fever.ppt
AmareDejene
 
2.1. Heart Failure.ppt
2.1. Heart  Failure.ppt2.1. Heart  Failure.ppt
2.1. Heart Failure.ppt
AmareDejene
 
Pneumonia - Copy.ppt
Pneumonia - Copy.pptPneumonia - Copy.ppt
Pneumonia - Copy.ppt
AmareDejene
 
ssi and wound.pptx
ssi and wound.pptxssi and wound.pptx
ssi and wound.pptx
AmareDejene
 

More from AmareDejene (13)

upper gastrointestinal lecture slide ppt
upper gastrointestinal lecture slide pptupper gastrointestinal lecture slide ppt
upper gastrointestinal lecture slide ppt
 
benigh perianal conditionsssssssss CI.pptx
benigh perianal conditionsssssssss CI.pptxbenigh perianal conditionsssssssss CI.pptx
benigh perianal conditionsssssssss CI.pptx
 
solid.pptx
solid.pptxsolid.pptx
solid.pptx
 
2.5. Stenotic v-2014.pptx
2.5. Stenotic v-2014.pptx2.5. Stenotic v-2014.pptx
2.5. Stenotic v-2014.pptx
 
2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt
 
2.8. Pericardial disease.pptx
2.8. Pericardial disease.pptx2.8. Pericardial disease.pptx
2.8. Pericardial disease.pptx
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
 
2.6. HTN.pptx
2.6. HTN.pptx2.6. HTN.pptx
2.6. HTN.pptx
 
2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
 
2.2. Acute Rheumatic Fever.ppt
2.2. Acute Rheumatic Fever.ppt2.2. Acute Rheumatic Fever.ppt
2.2. Acute Rheumatic Fever.ppt
 
2.1. Heart Failure.ppt
2.1. Heart  Failure.ppt2.1. Heart  Failure.ppt
2.1. Heart Failure.ppt
 
Pneumonia - Copy.ppt
Pneumonia - Copy.pptPneumonia - Copy.ppt
Pneumonia - Copy.ppt
 
ssi and wound.pptx
ssi and wound.pptxssi and wound.pptx
ssi and wound.pptx
 

Recently uploaded

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
Dr. Mulla Adam Ali
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 

Recently uploaded (20)

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 

2.5. Regurgitant Murmurs.pptx

  • 4. pathophysiology The total stroke volume ejected by the LV is increased in patients with AR.  the increase in LV end-diastolic volume (i.e., increased preload) provides hemodynamic compensation. In compensated AR , LV systolic function is maintained through the combination of chamber dilation and hypertrophy (eccentric hypertrophy).
  • 5. CON… As the LV decompensates, LVcompliance declines, and LV end-diastolic pressure and volume rise. Ultimately, these adaptive measures fail. As LV function deteriorates, the end- diastolic volume rises further and the forward stroke volume and EF decline.
  • 6. Con…  In patients with acute severe AR, the LV is unprepared for the regurgitant volume load.  LV compliance is normal or reduced, and LV diastolic pressures rise rapidly, occasionally to levels >40 mmHg.  The LV pressure may exceed the LA pressure toward the end of diastole, and this reversed pressure gradient closes the mitral valve prematurely.
  • 7. Con…  Myocardial ischemia may occur in patients with AR because myocardial oxygen requirements are elevated by  LV dilation  hypertrophy  elevated LV systolic tension
  • 9. EPIDEMIOLOGY  The prevalence of AR varied with age and disease severity.  For mild AR, the prevalence was  3.7% in men at ages 50 to 59  12.1 % …. …. 60 to 69  12.2 % …….. ….70 to 83  moderate to severe AR, the prevalence was 0.5, 0.6, and 2.2 % in men at ages 50 to 59, 60 to 69, and 70 to 83, respectively
  • 10. Con… three-fourths of patients with pure or predominant AR are men. women predominate among patients with primary valvular AR who have associated rheumatic mitral valve disease.
  • 11. Presentation  History  Hx cardiac illness  Duration (acute or chronic)  Palpitations  exertional dyspnea  Anginal pain  do not respond satisfactorily to sublingual nitroglycerin  ankle edema
  • 12. Con… Physical Findings Arterial Pulse water-hammer Corrigan's pulse Quincke's pulse pistol-shot(Traube's sign) to-and-fro murmur (Duroziez's sign) The arterial pulse pressure (widended)
  • 13. Con…  Bobbing motion of the head with each systole(De Musset’s sign)  A rapidly rising "water-hammer" pulse, which collapses suddenly as arterial pressure falls rapidly during late systole and diastole  Prominent carotid artery pulsations(Corrigan's pulse)  Quincke's pulse (capillary pulsations)
  • 14.  Traube's sign, A booming "pistol-shot" sound can be heard over the femoral arteries  Duroziez's sign, A to-and-fro murmur is audible if the femoral artery is lightly compressed with a stethoscope.  Wide pulse pressure, elevation of the systolic pressure and a depression of the diastolic pressure.
  • 15. Con…  Precordial exam  the LV impulse is heaving and displaced laterally and inferiorly.  A diastolic thrill is often palpable along the left sternal border  A prominent systolic thrill may be palpable in the suprasternal notch  A2 is usually absent, S3 and systolic ejection sound are frequently audible, S4.  A high-pitched, blowing, decrescendo diastolic murmur, heard best in the 3rd intercostal space along the LSB.
  • 16. Con…  A mid-systolic ejection murmur is frequently audible and best at the base of the heart  Austin Flint murmur, a soft, low-pitched, rumbling mid-diastolic murmur.  The auscultatory features of AR are intensified by strenuous handgrip, which augments systemic resistance
  • 17. Progress…  Asymptomatic patients with left ventricular dysfunction, however, develop symptoms (angina, heart failure) at a rate of greater than 25 % per year.  symptomatic patients with severe aortic regurgitation have an expected mortality that exceeds 10 %per year.
  • 18. Stages /AHA valvular heart disease 2014
  • 19. Work up ECG:  chronic severe AR,Left LV hypertrophy. ◦ ST-segment depression and T-wave inversion in leads I, aVL, V5, and V6 ("LV strain"). ◦ Left axis deviation and/or QRS prolongation CXR:  Cardiomegaly, aortic calcification, aortic root dilatation
  • 20. Echocardiography  is useful in determining the cause of AR  thickening and failure of coaptation of the leaflets may be noted  Colour flow Doppler ECHO is very sensitive in the detection of AR,
  • 22. Medical treatment - Diuretics, digoxin, salt restriction - Vasodilators - Endocarditis prophylaxis ◦ Without surgery, death usually occurs within 4 years of developing angina and within 2 years after onset of heart failure.
  • 23. surgical  AVR(aortic valve replacement ) is indicated for the Tx of severe AR in symptomatic pts irrespective of LV function It should be carried out in asymptomatic pts with severe AR and progressive LV dysfunction defined by LVEF <50%, an LV end-systolic dimension >55mm , or
  • 24.  without indications for operation should be followed by clinical and ECHO examination every 3–12 months
  • 25.
  • 26. 2014 AHA/ACC Valvular Heart Disease Guideline
  • 27.
  • 29. Con…  Valve leaflets - myxomatous degeneration - rheumatic heart disease - infective endocarditis  Chordae tendinae - congenital, infective endocarditis, trauma, rheumatic fever, myxomatous  Papillary muscles - myocardial ischaemia, congenital abnormalities, infiltrative disease  Mitral annulus - dilatation eg. ischaemic or dilated cardiomyopathy - calcification due to degeneration, hypertension, diabetes, CKD
  • 30. Pathophysiology  The resistance to LV emptying (LV afterload) is reduced in pts with MR. As a consequence, the LV is decompressed into the LA during ejection.  The initial compensation to MR is more complete LV emptying leading to a reduced end-systolic LV volume.  As regurgitation becomes chronic, the LV end- diastolic volume increases and the end-systolic volume returns to normal.  The resultant increase in LV end-diastolic volume and mitral annular diameter may create a vicious circle in which “MR begets more MR.
  • 31. Ctd.  In patients with chronic MR , LV mass is also increased (typical volume overload (eccentric) hypertrophy)  The reduced afterload in MR permits maintenance of ejection fraction in the normal to supranormal range ,thus even a modest reduction in the EF (<60%) reflects significant dysfunction.  As the disease progress and LV contractile function deteriorates LV volume increases accompanied by a reduced forward CO.
  • 32. Clinical features  Symptoms usually occur with LV decompensation: Fatigue, exertional dyspnea, and orthopnea are the most prominent complaints in pts with chronic severe MR  Palpitations with AF  Sx and SSx of right-sided HF in pt who have associated pulmonary vascular disease and marked pulmonary HTN  Acute pulmonary edema is common in pts with acute severe MR b/c of markedly increase LA and pulmonary venous pressures.
  • 33. Chronic versus Acute MR Finding Chronic MR Acute MR Symptoms subtle onset obvious Appearance normal/mildly severely ill dyspnoeic Tachycardia not striking always present Apex beat displaced not displaced Systolic thrill common absent Murmur harsh pansystolic soft or absent early systolic component ECG-LVH usually present absent CXR severe cardiomegaly normal heart size
  • 34. Physical findings - Pulse: sharp upstroke - BP is usually normal - Apex: displaced, hyperdynamic ◦ A systolic thrill is often palpable at the cardiac apex ◦ In acute severe MR, BP may be reduced with a narrow pulse pressure, the apical impulse is not displaced, and signs of pulmonary congestion are prominent. ◦ S1 is absent or soft ◦ S3
  • 35. CON… ◦ S 4 in acute severe MR ◦ holosystolic murmur most prominent at the apex and radiates to the axilla, intensified by isometric exercise (handgrip) ◦ In pts with ruptured chordae tendineae, the systolic murmur may have a cooing or "sea gull" quality
  • 36. Ctd.  ECG ◦ evidence of LA enlargement ◦ AF ◦ signs of LV hypertrophy  Chest X-Ray ◦ Pulmonary venous congestion, interstitial edema, and Kerley B lines ◦ Calcification of the mitral annulus may be visualized
  • 37. Ctd. Natural history  The natural history of chronic MR depends on the volume of regurgitation, the state of the myocardium and the underlying cause.  Preoperative LV end-systolic volume or diameter is a useful predictor of function and postoperative survival in chronic MR.  The preoperative LV end-systolic diameter should be < 45mm to ensure normal postoperative LV function
  • 38. CON... Severe MR is defined by a regurgitant volume 60 mL/beat, regurgitant fraction (RF) 50%, effective regurgitant orifice area 0.40 cm2
  • 39. MR and Colour flow imaging of MR
  • 40. Management strategy for pts with chronic severe MR
  • 41. Medical treatment  Symptomatic patients may benefit from the following drug therapy while awaiting surgery:  ACE inhibitors  Diuretics  Digoxin / Beta-blockers in presence of atrial fibrillation. Plus Warfarin with a target INR of 2–3.  Endocarditis prophylaxis  Pts with acute severe MR require urgent stabilization and preparation for surgery. [Diuretics, intravenous vasodilators (sodium nitroprusside), and even IABC].
  • 42. Surgical treatment  Surgery is indicated ◦ If symptoms developed or LV end systolic diameter ≥45mm ◦ recent-onset AF and pulmonary hypertension, (a PA pressure 50 mmHg at rest or 60 mmHg with exercise). ◦ For asymptomatic pts when LV dysfunction is progressive, with LVEF declining below 60% and/or ESD on ECHO rising above 40 mm.  Mitral valve repair or replacement. ◦ Mitral repair and valvuloplasty maintain LV function to a relatively greater degree and avoids the need for chronic anticoagulation.  In pts with significantly impaired LV function (EF <30%), the risk of surgery rises, the recovery of LV performance is incomplete, and the long-term survival is reduced.
  • 43. Ctd.  Natural history  Benign prognosis in most patients  Complications may occur in patients with a systolic murmur, thickened leaflets, an increased LV or LA size, especially in men > 45 years old • Complications include progressive MR, infective endocarditis, cerebral emboli, arrhythmias and rarely sudden death.
  • 44. summary  In patients with chronic MR , LV mass is also increased (typical volume overload (eccentric) hypertrophy - Apex: displaced, hyperdynamic ◦ A systolic thrill is often palpable at the cardiac apex. ◦ a regurgitant volume < 60 mL/beat….severMR